OrbiMed Capital GP VII LLC, 10% Owner at Passage BIO, Inc. (PASG), bought 914,302 shares at $18.00 ($6.7M) on 2020-02-28, disclosed to the SEC on 2020-03-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 373,300 | $6.7M | 100.0% |
| 2 | $0.00 | 541,002 | $0 | 0.0% |
| Total | $7.35 avg | 914,302 | $6.7M | 100% |
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |